29 results
Behcet's Syndrome - Treatment
Ulcers:
 • Treatment: Topical steroids
 • Prevention: Colchicine
 • Azathioprine for refractory disease
Arthritis:
Behcet's Syndrome ... refractory disease Skin ... Behcets #disease #Syndrome ... #Treatment #management ... #pharmacology #
Systemic Lupus Erythematosus - Summary
Antinuclear (ANA) - 95% - Initial screening test
Anti-dsDNA - 50%
 • Associated
Associated with skin ... block • Sjogren syndrome ... severe disease Treatment ... Hydroxychloroquine *Short ... #rheumatology #management
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... in setting of short ... highlighted circle= clinical ... #COVID19 #Pharmacology ... #Table #Management
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Adjuvant therapies in critical ... respiratory distress syndrome ... InfectiousDiseases #Infections #Pharmacology ... #Management #Treatment
SAPHO Syndrome Summary

What?
SAPHO syndrome is a rare chronic inflammatory disorder of bone, joint, and skin characterized
Rheumatic pain Clinical ... anterior chest wall, parts ... Diagnosis: • A clinical ... and lower jaw Treatment ... Rheumatology #diagnosis #management
Secondary Syphilis Rash
Secondary syphilis is the most contagious of all the stages of this disease, and
Skin rash and malaise ... , but without treatment ... reddish brown spots ... Rash #Diagnosis #Clinical ... #Photo #Dermatology
Behçet's Syndrome
Systemic disease associated with inflammation of multiple organs, small-vessel vasculitis and large-vessel vasculopathy
Epidemiology:
 • Young
association • M > F Clinical ... response to local skin ... (Clinical Dx). ... Arthritis, AS Treatment ... #diagnosis #management
Smoking Cessation Management
Nicotine Replacement Therapy (NRT):
Long-Acting NRT:
 • Patch: Wear for 24 hours at a time.
Smoking Cessation Management ... sites to minimize skin ... Short-Acting NRT ... after FDA-approved treatments ... #pharmacology #
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
meningococcal, H1N1) Clinical ... Guillain-Barre Clinical ... • Weakness: Starts ... #diagnosis #management ... #treatment #neurology
Statin Induced Muscle Toxicity - Summary

Clinical Presentation:
 • Elevations of serum creatine kinase with proximal myalgia
Toxicity - Summary Clinical ... weakness without skin ... IU/I • SAMS clinical ... myopathy #diagnosis #management ... #treatment